There is reason for concern about fascism rising in the United States. The reason is primarily Trumpism, followed by racism, followed by right-wing seditionist impulses.
Francis Collins will step down as director of NIH by the end of 2021, closing out a chapter in his career as the longest-serving presidentially appointed NIH director.
Thomas A. Waldmann, chief emeritus of the NCI Lymphoid Malignancies Branch and NIH Distinguished Investigator, died Sept. 25. He was 91.
Emil J Freireich, a trailblazing oncologist who developed groundbreaking therapies for childhood leukemia, and one of the 60 original members of ASCO, died Feb. 1.
American cancer patients have collectively gained up to 14 million years of life since 1980 as a result of NCI-funded cancer trials conducted by the National Clinical Trials Network, a study led by SWOG Cancer Research Network found.
Randall F. Holcombe has a goal: earn the NCI designation for University of Vermont Cancer Center. Or, to be precise, earn back the NCI designation.
NIH ignored my report of sexual misconduct by Axel Grothey—and danced around questions from Congress
While I’m glad that in a recent response to questions from a congressional committee NIH recognizes that sexual harassment is a major obstacle in the advancement of science and has put new processes in place to address this issue, the letter does not adequately address the lack of response in the case of Dr. Grothey.
Martin “Mac” Cheever, a Fred Hutchinson Cancer Research Center physician-scientist who was a pioneer in the development of immunotherapies, died on Sept. 23 from complications following heart surgery. He was 77. Friends and colleagues note Cheever’s calm demeanor, generosity and wit. As an oncologist, he was respected for his work as one of the first […]
In real time, the Cancer History Project is documenting a growing collection of podcasts in the oncology sphere, focused on oral histories, the history of cancer advocacy, the evolution of treatment, and more.
Women who report sexual misconduct to NIH may find that their complaints have a limited shelf life—these complaints may become null, or at least ineligible for “even a cursory review” once perpetrators cut ties with NIH.
